Nicola Casiraghi Selected Research

Androgen Receptors (Androgen Receptor)

1/2020	Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
11/2015	Plasma AR and abiraterone-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Casiraghi Research Topics

Disease

4	Neoplasms (Cancer) 11/2021 - 11/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 11/2015
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Adenocarcinoma 01/2020
1	Scrapie 11/2013
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2013

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2015
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 11/2015
2	Circulating Tumor DNAIBA 01/2020 - 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2021
1	NucleotidesIBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	Hormones (Hormone)IBA 11/2015
1	abirateroneIBA 11/2015
1	Amino Acids FDA Link 11/2015
1	Prion ProteinsIBA 11/2013
1	Protein Isoforms (Isoforms)IBA 11/2013

Therapy/Procedure

3	Castration 01/2020 - 11/2015
1	Aftercare (After-Treatment) 11/2021